Executives

5

Board of Directors

1

Standigm Board of Director

1 Board of directors

Standigm has 1 board of directors, including Jinsoo Lee.

Name

Firm

Work History

Other Seats

Jinsoo Lee

Standigm

Name

Jinsoo Lee

Firm

Work History

Other Seats

Standigm

Standigm Management Team

5 Team Members

Standigm has 5 executives. Standigm's current Founder, Chief Executive Officer is Jinhan Kim.

Name

Work History

Title

Status

Jinhan Kim

Founder, Chief Executive Officer

Current

Sang Ok Song

Founder, Chief Operating Officer

Current

So Jeong Yun

Founder, Chief Revenue Officer

Current

Donggyun Kang

Chief Financial Officer

Current

Hanjo Kim

Senior Vice President

Current

Name

Jinhan Kim

Sang Ok Song

So Jeong Yun

Donggyun Kang

Hanjo Kim

Work History

Title

Founder, Chief Executive Officer

Founder, Chief Operating Officer

Founder, Chief Revenue Officer

Chief Financial Officer

Senior Vice President

Status

Current

Current

Current

Current

Current

You May Also Like

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Insilico Medicine Logo
Insilico Medicine

Insilico Medicine develops a range of generative adversarial networks (GANs) and reinforcement learning approaches to identify protein targets, generate molecular structures with specified properties, and generate synthetic data. The company provides pharmaceutical and biotechnology companies with artificial intelligence solutions that transform the way innovative medicines and treatments are discovered and accelerate research and development. The company was founded in 2014 and is based in Hong Kong.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

B
BERG

BERG is a Boston-based biopharma company focused on taking a bold "back to biology" approach to therapeutic discovery using its unique AI-based Interrogative Biology platform. This platform combines patient biology and artificial intelligence-based analytics to engage the differences between healthy and disease environments. The patient's own biology drives the platform's results and guides the company in the discovery and development of drugs, diagnostics and healthcare applications. Its platform utilizes patient population health data to bring actionable Patient Intelligence to precision medicine applications. This means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems.

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

Healx Logo
Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform leverages public and proprietary biomedical data and features a knowledge graph for rare diseases.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.